Sensing G protein-coupled receptor activation

Neuropharmacology

Volumn 60, Issue 1, 2011, Pages 45-51

  Ambrosio, Manuela ^a   Zürn, Alexander ^a   Lohse, Martin J ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Fluorescein arsenical hairpin binder (FlAsH); Fluorescence resonance energy transfer (FRET); G protein coupled receptors (GPCR); Green fluorescent protein (GFP); Adrenergic receptors

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CYAN FLUORESCENT PROTEIN; G PROTEIN COUPLED RECEPTOR; RHODOPSIN; YELLOW FLUORESCENT PROTEIN;

ADRENERGIC STIMULATION; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; FLUORESCENCE RESONANCE ENERGY TRANSFER; ISOMERIZATION; LIGAND BINDING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

EID: 78149496369     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2010.08.006     Document Type: Review

References (47)

1. Ahuja S., Hornak V., Yan E.C., Syrett N., Goncalves J.A., Hirshfeld A., Ziliox M., Sakmar T.P., Sheves M., Reeves P.J., Smith S.O., Eilers M. Helix movement is coupled to displacement of the second extracellular loop in rhodopsin activation. Nat. Struct. Mol. Biol. 2009, 16:168-175.
2. Ahuja S., Smith S.O. Multiple switches in G protein-coupled receptor activation. Trends Pharmacol. Sci. 2009, 30:494-502.
3. Arshavsky V.Y. Rhodopsin phosphorylation: from terminating single photon responses to photoreceptor dark adaptation. Trends Neurosci. 2002, 25:124-126.
4. Azzi M., Charest P.G., Angers S., Rousseau G., Kohout T., Bouvier M., Pineyro G. β-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:11406-11411.
5. 2-adrenoceptor provide evidence for agonist-directed signaling. Mol. Pharmacol. 2003, 64:1357-1369.
6. Bokoch M.P., Zou Y., Rasmussen S.G., Liu C.W., Nygaard R., Rosenbaum D.M., Fung J.J., Choi H.J., Thian F.S., Kobilka T.S., Puglisi J.D., Weis W.I., Pardo L., Prosser R.S., Mueller L., Kobilka B.K. Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor. Nature 2010, 463:108-112.
7. Ballesteros J., Weinstein H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci. 1995, 25:366-428.
8. 2-adrenergic G protein-coupled receptor. Science 2007, 318:1258-1265.
9. i coupling. J. Biol. Chem. 1995, 270:24753-24760.
10. i coupling domains. J. Biol. Chem. 1996, 271:12826-12832.
11. 2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy. Mol. Pharmacol. 2006, 70:1575-1584.
12. Galandrin S., Oligny-Longpre G., Bouvier M. The evasive nature of drug efficacy: implications for drug discovery. Trends Pharmacol. Sci. 2007, 28:423-430.
13. Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr. Rev. 2000, 21:90-113.
14. 2 adrenoceptor. EMBO J. 1997, 16:6737-6747.
15. 2 adrenergic receptor. Evidence for ligand-specific conformational changes. J. Biol. Chem. 1995, 270:28268-28275.
16. 2 adrenergic receptor. J. Biol. Chem. 2001, 276:24433-24436.
17. 2 adrenergic receptor. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:5997-6002.
18. 2-adrenoceptor: insights from fluorescence resonance energy transfer studies. J. Biol. Chem. 2007, 282:13895-13905.
19. Hoffmann C., Gaietta G., Bünemann M., Adams S.R., Oberdorff-Maass S., Behr B., Vilardaga J.P., Tsien R.Y., Ellisman M.H., Lohse M.J. A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells. Nat. Methods 2005, 2:171-176.
20. Hoffmann C., Zürn A., Bünemann M., Lohse M.J. Conformational changes in G-protein-coupled receptors-the quest for functionally selective conformations is open. Br. J. Pharmacol. 2008, 153(Suppl. 1):S358-S366.
21. Hofmann K.P., Scheerer P., Hildebrand P.W., Choe H.W., Park J.H., Heck M., Ernst O.P. A G protein-coupled receptor at work: the rhodopsin model. Trends Biochem. Sci. 2009, 34:540-552.
22. Hubbell W.L., Altenbach C., Hubbell C.M., Khorana H.G. Rhodopsin structure, dynamics, and activation: a perspective from crystallography, site-directed spin labeling, sulfhydryl reactivity, and disulfide cross-linking. Adv. Protein Chem. 2003, 63:243-290.
23. Kenakin T. New concepts in drug discovery: collateral efficacy and permissive antagonism. Nat. Rev. Drug Discov. 2005, 4:919-927.
24. Kenakin T. Functional selectivity through protean and biased agonism: who steers the ship?. Mol. Pharmacol. 2007, 72:1393-1401.
25. Kobilka B.K. G protein coupled receptor structure and activation. Biochim. Biophys. Acta 2007, 1768:794-807.
26. Kobilka B.K., Deupi X. Conformational complexity of G-protein-coupled receptors. Trends Pharmacol. Sci. 2007, 28:397-406.
27. Lagerstrom M.C., Schioth H.B. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat. Rev. Drug Discov. 2008, 7:339-357.
28. Leff P. The two-state model of receptor activation. Trends Pharmacol. Sci. 1995, 16:89-97.
29. Lefkowitz R.J. The superfamily of heptahelical receptors. Nat. Cell Biol. 2000, 2:E133-E136.
30. Monod J., Wyman J., Changeux J.P. On the nature of allosteric transitions: a plausible model. J. Mol. Biol. 1965, 12:88-118.
31. i-protein heterotrimer. J. Biol. Chem. 2006, 281:24506-24511.
32. Nygaard R., Frimurer T.M., Holst B., Rosenkilde M.M., Schwartz T.W. Ligand binding and micro-switches in 7TM receptor structures. Trends Pharmacol. Sci. 2009, 30:249-259.
33. Park J.H., Scheerer P., Hofmann K.P., Choe H.W., Ernst O.P. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 2008, 454:183-187.
34. 2A-adrenoceptor. Br. J. Pharmacol. 2003, 140:347-358.
35. 2 adrenergic G-protein-coupled receptor. Nature 2007, 450:383-387.
36. Rosenbaum D.M., Rasmussen S.G., Kobilka B.K. The structure and function of G-protein-coupled receptors. Nature 2009, 459:356-363.
37. Scheerer P., Park J.H., Hildebrand P.W., Kim Y.J., Krauss N., Choe H.W., Hofmann K.P., Ernst O.P. Crystal structure of opsin in its G-protein-interacting conformation. Nature 2008, 455:497-502.
38. Stephenson R.P. A modification of receptor theory. Br. J. Pharmacol. Chemother. 1956, 11:379-393.
39. 2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists. J. Biol. Chem. 2005, 280:22165-22171.
40. 2 adrenoceptor. Kinetic evidence for intermediate conformational states. J. Biol. Chem. 2004, 279:686-691.
41. Urban J.D., Clarke W.P., von Zastrow M., Nichols D.E., Kobilka B., Weinstein H., Javitch J.A., Roth B.L., Christopoulos A., Sexton P.M., Miller K.J., Spedding M., Mailman R.B. Functional selectivity and classical concepts of quantitative pharmacology. J. Pharmacol. Exp. Ther. 2007, 320:1-13.
42. Vilardaga J.P., Bünemann M., Krasel C., Castro M., Lohse M.J. Measurement of the millisecond activation switch of G protein-coupled receptors in living cells. Nat. Biotechnol. 2003, 21:807-812.
43. Vilardaga J.P., Steinmeyer R., Harms G.S., Lohse M.J. Molecular basis of inverse agonism in a G protein-coupled receptor. Nat. Chem. Biol. 2005, 1:25-28.
44. Vogel R., Siebert F. Conformations of the active and inactive states of opsin. J. Biol. Chem. 2001, 276:38487-38493.
45. 2-adrenergic receptor. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:9276-9281.
46. 2-adrenoceptor. Nat. Chem. Biol. 2006, 2:417-422.
47. 2a-adrenergic receptor activation reveals distinct agonist-specific conformational changes. Mol. Pharmacol. 2009, 75:534-541.